VEGFA and wet macular degeneration: The use of anti-VEGF injections has proven to be the mainstay of treatment for several retinal diseases, including wet age-related macular degeneration (ARMD), macular edema secondary to diabetes and retinal vein occlusion, myopic choroidal neovascularization (CNV), and proliferative diabetic retinopathy1.